Merck Discontinues Substance P Depression Compound After Failed Trial
Merck is abandoning its efforts to develop the substance P antagonist aprepitant (MK-0869) for treatment of depression
Merck is abandoning its efforts to develop the substance P antagonist aprepitant (MK-0869) for treatment of depression